Advertisement
Review| Volume 147, ISSUE 2, P120-123, December 2009

Contribution of myo-inositol to reproduction

Published:September 24, 2009DOI:https://doi.org/10.1016/j.ejogrb.2009.09.008

      Abstract

      Myo-inositol is involved in several aspects of human reproduction.
      Elevated concentrations of myo-inositol in human follicular fluids appear to play a positive function in follicular maturity and provide a marker of good quality oocytes.
      Nevertheless its positive role in PCOS women is a consequence of a defect in the insulin signaling pathway (inositol-containing phosphoglycan mediators) that seems to be primarily implicated in the pathogenesis of insulin resistance.
      This article will review the involvement of inositol in female reproduction. After describing the biologic function of inositol and its derivatives, studies are quoted in which the role of inositol in fertility, oogenesis, and polycystic ovary syndrome are examined.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Beemster P.
        • Groenen P.
        • Steegers-Theunissen R.
        Involvement of inositol in reproduction.
        Nutr Rev. 2002; 60: 80-87
        • Kane M.T.
        The effects of water soluble vitamins on the expansion of rabbit blastocysts.
        J Exp Zool. 1988; 245: 220-223
        • Dove S.K.
        • Michell R.H.
        Inositol lipids and phosphates in cell control.
        Neurotransmissions. 2000; 16: 3-17
        • Berridge M.J.
        Inositol lipids and cell proliferation.
        Biochim Biophys Acta. 1987; 907: 33-45
        • Downes C.P.
        The cellular function of myo-inositol.
        Biochem Soc Trans. 1989; 17: 259-268
        • Fahy M.M.
        • Kane M.T.
        Incorporation of [3H] inositol into phosphoinositides and inositol phosphates by rabbit blastocysts.
        Mol Reprod Dev. 1993; 34: 391-395
        • Holm P.
        • Booth P.J.
        • Schmidt M.H.
        • Greve T.
        • Callesen H.
        High bovine blastocyst development in a static in vitro production system using SOFaa medium supplemented with sodium citrate and myo-inositol with or without serum-proteins.
        Theriogenology. 1999; 52: 683-700
        • Berridge M.J.
        • Irvine R.F.
        Inositol phosphate and cell signalling.
        Nature. 1989; 306: 197-205
        • Holub B.J.
        Metabolism and function of myo-inositol and inositol phospholipids.
        Ann Rev Nutr. 1986; 6: 563-597
        • Kane M.T.
        • Norris M.
        • Harrison R.A.P.
        Uptake and incorporation of inositol by preimplantation mouse embryos.
        J Reprod Fert. 1992; 95: 617-625
        • Berridge MJ
        Inositol trisphosphate and calcium signalling.
        Nature. 1993; 361: 315-325
        • Downes C.P.
        • Currie R.A.
        Lipid signalling.
        Curr Biol. 1998; 8: R865-R867
        • Balla T.
        Inositol-lipid binding motifs: signal integrators through protein-lipid and protein–protein interactions.
        J Cell Sci. 2005; 118: 2093-2104
        • Divecha N.
        • Irvine R.F.
        Phospholipid signalling.
        Cell. 1995; 80: 269-278
        • Herbert M.
        • Gillespie J.I.
        • Murdoch A.P.
        Development of calcium signaling mechanisms during maturation of human oocytes.
        Mol Hum Reprod. 1997; 3: 965-973
        • Berridge M.J.
        • Downes C.P.
        • Hanley M.R.
        Neural developmental actions of lithium: a unifying hypothesis.
        Cell. 1989; 59: 411-419
        • Berridge M.J.
        Regulation of calcium spiking in mammalian oocytes through a combination of inositol trisphosphate-dependent entry and release.
        Mol Hum Reprod. 1996; 2: 383-390
        • Carroll J.
        • Jones K.T.
        • Whittingham D.G.
        Ca2+ release and the development of Ca2+ release mechanisms during oocyte maturation: a prelude to fertilization.
        Rev Reprod. 1996; 1: 137-143
        • Tesarik J.
        • Sousa M.
        Mechanism of calcium oscillations in human oocytes: a two-store model.
        Mol Hum Reprod. 1996; 2: 383-385
        • Mehlmann L.M.
        • Mikoshiba K.
        • Kline D.
        Redistribution and increase in cortical inositol 1,4,5-trisphosphate receptors after meiotic maturation of the mouse oocyte.
        Dev Biol. 1996; 180: 489-498
        • Goud P.T.
        • Goud A.P.
        • Van Oostveldt P.
        • Dhont M.
        Presence and dynamic redistribution of type 1 inositol 1,4,5-trisphosphate receptors in human oocytes and embryos during in vitro maturation, fertilization and early cleavage divisions.
        Mol Hum Reprod. 1999; 5: 441-451
        • Goud P.T.
        • Goud A.P.
        • Leybaert L.
        • et al.
        Inositol 1,4,5-trisphosphate receptor function in human oocytes: calcium responses and oocyte activation-related phenomena induced by photolytic release of InsP3 are blocked by a specific antibody to the type I receptor.
        Mol Hum Reprod. 2002; 8: 912-918
        • Pesty A.
        • Lefevre B.
        • Kubiak J.
        • Geraud G.
        • Tesarik J.
        • Maro B.
        Mouse oocyte maturation is affected by lithium via the polyphosphoinositide metabolism and the microtubule network.
        Mol Reprod Dev. 1994; 38: 187-199
        • Delisle S.
        • Blondel O.
        • Longo F.J.
        • Schnabel W.E.
        • Bell G.I.
        • Welsh M.J.
        Expression of inositol 1,4,5-trisphosphate receptors changes the Ca2+ signal of Xenopus oocytes.
        Am J Physiol-cell Physiol. 1996; 270: c1255-c1261
        • Chiu T.T.Y.
        • Rogers M.S.
        • Briton-Jones C.
        • Haines C.
        Effects of myo-inositol on the in vitro maturation and subsequent development of mouse oocytes.
        Hum Reprod. 2003; 18: 408-416
        • Chiu T.T.
        • Rogers M.S.
        • Law E.L.
        • Briton-Jones C.M.
        • Cheung L.P.
        • Haines C.J.
        Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
        Hum Reprod. 2002; 17: 1591-1596
        • Paolo G.D.
        • De Camilli P.
        Phosphoinositides in cell regulation and membrane dynamics.
        Nature. 2006; 443: 651-657
        • Larner J.
        Mediators of postreceptor action of insulin.
        Am J Med. 1983; 74: 38-51
        • Larner J.
        Insulin-signaling mechanisms. Lessons from the old testament of glycogen metabolism and the new testament of molecular biology.
        Diabetes. 1988; 37: 262-275
        • Saltiel A.R.
        Second messengers of insulin action.
        Diabetes Care. 1990; 13: 244-256
        • Nestler E.
        • Jakubowicz D.J.
        • Reamer P.
        • et al.
        Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome.
        N Engl J Med. 1999; 340: 1314-1320
        • Gerli S.
        • Mignosa M.
        • Di Renzo G.C.
        Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
        Eur Rev Med Pharmacol Sci. 2003; 7: 151-159
        • Gerli S.
        • Papaleo E.
        • Ferrari A.
        • et al.
        Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.
        Eur Rev Med Pharmacol Sci. 2007; 11: 347-354
        • Papaleo E.
        • Unfer V.
        • Baillargeon J.P.
        • et al.
        Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
        Gynecol Endocrinol. 2007; 23: 700-703
        • Genazzani A.D.
        • Lanzoni C.
        • Ricchieri F.
        • Jasonni V.M.
        Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome.
        Gynecol Endocrinol. 2008; 24: 139-144
        • Baillargeon J.P.
        • Diamanti-Kandarakis E.
        • Ostlund Jr., R.E.
        • Apridonidze T.
        • Iuorno M.J.
        • Nestler J.E.
        Altered d-chiro-inositol urinary clearance in women with polycystic ovary syndrome.
        Diabetes Care. 2006; 29: 300-305
        • Baillargeon J.P.
        • Nestler J.E.
        • Ostlund R.E.
        • Apridonidze T.
        • Diamanti-Kandarakis E.
        Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.
        Hum Reprod. 2008; 23 ([Epub 2008 Mar 29]): 1439-1446
        • Papaleo E.
        • Unfer V.
        • Baillargeon J.P.
        • Fusi F.
        • Occhi F.
        • De Santis L
        Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
        Fertil Steril. 2009; 91: 1750-1754
        • Minozzi M.
        • D’Andrea G.
        • Unfer V.
        Treatment of hirsutism with myo-inositol: a prospective clinical study.
        Reprod Biomed Online. 2008; 17: 579-582
        • Jousan F.D.
        • Oliveira L.J.
        • Hansen P.J.
        Short-term culture of in vitro produced bovine preimplantation embryos with insulin-like growth factor-i prevents heat shock-induced apoptosis through activation of the phosphatidylinositol 3-kinase/Akt pathway.
        Mol Reprod Dev. 2008; 75: 681-688
        • Lowther K.M.
        • Weitzman V.N.
        • Maier D.
        • Mehlmann L.M.
        Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes.
        Biol Reprod. 2009; 81 ([Epub 2009 Mar 18]): 147-154
      1. Consensus on infertility diagnosis Rotterdam.

      2. Consensus on infertility treatment related to polycystic ovary syndrome. The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group* March 2–3, 2007, Thessaloniki, Greece. Hum Reprod 2007;23:462–477.

        • Palomba S.
        • Orio F.
        • Zullo F.
        Ovulation induction in women with polycystic ovary syndrome.
        Fertil Steril. 2008; 86: s26-s27
      3. Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome; 2006.